Clinical Trial Update: Protection From Food Induced Anaphylaxis by Reducing the Serum Level of Specific IgE (Protana). [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Protana aiming to reduce specific IgE serum levels to protect from food-induced anaphylaxis; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• Protana

Snippet

Sponsor: Carsten Bindslev-Jensen | Conditions: Food Allergy | Phase 4 | Status: TERMINATED